Malaria in Pregnancy Consortium (Antimalarial combination treatments in African pregnant women with P. falciparum infection) Institute of Tropical Medicine
General
To determine the safety and efficacy of 4 ACTs (amodiaquine-artesunate, AQ-AS, dihydroartemisinin-piperaquine, DHA-PQ, artemether-lumefantrine, AL, Mefloquine-artesunate, MQAS) when administered to pregnant women with P. falciparum infection during the second and the third trimester and collect explanatory variables for treatment failure (PCR-corrected) and for recurrent parasitaemia. Safety will be determined ...